Was The Smart Money Right About Alnylam Pharmaceuticals, Inc. (ALNY)?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Posts Tagged ‘NASDAQ:ALNY’
Hedge Funds Are Piling Into Alnylam Pharmaceuticals, Inc. (ALNY)
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
5 Pharmaceutical Stocks to Buy According to Brandon Haley’s Holocene Advisors
In this article, we take a look at the 5 pharmaceutical stocks to buy according to Brandon Haley’s Holocene Advisors.
10 Best Healthcare Stocks to Buy According to Greg Martinez’s Parkman Healthcare Partners
In this article, we discuss the 10 best healthcare stocks to buy according to Greg Martinez's Parkman Healthcare Partners.
Analysts are Increasing Price Targets of Tesla and 9 Other Stocks
In this article, we discuss the 10 stocks that analysts are increasing price targets of.
11 Best Genomic Stocks to Buy Now
In this article, we will take a look at the 11 best genomic stocks to buy now.
Alnylam Pharmaceuticals, Inc. (ALNY) Fell Out Of Favor With Hedge Funds?
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end...
5 Pharmaceutical Stocks to Buy Today According to Tiger Cub Billionaire Lee Ainslie
In this article, we will discuss 5 pharmaceutical stocks to buy today according to Tiger Cub Billionaire Lee Ainslie.
Hedge Funds Aren’t Crazy About Alnylam Pharmaceuticals, Inc. (ALNY) Anymore
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million holdings threshold to file a report that shows their positions at the end of...
Is ALNY Stock A Buy or Sell?
In this article we will take a look at whether hedge funds think Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) is a good investment right now.
Is ALNY A Good Stock To Buy Now According To Hedge Funds?
At Insider Monkey, we pore over the filings of nearly 817 top investment firms every quarter, a process we have now completed for the latest reporting period.
Were These Hedge Funds Wrong About Alnylam Pharmaceuticals, Inc. (ALNY)?
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Hedge Funds Have Never Been This Bullish On Alnylam Pharmaceuticals, Inc. (ALNY)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Did Hedge Funds Make The Right Call On Alnylam Pharmaceuticals, Inc. (ALNY) ?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Alnylam Pharmaceuticals, Inc. (ALNY): Hedge Funds Are Getting Bullish
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Were Hedge Funds Right About Piling Into Alnylam Pharmaceuticals (ALNY)?
We hate to say this but, we told you so.
How Did Alnylam Pharmaceuticals, Inc. (ALNY) Compare Against Top Hedge Fund Stocks in 2019?
It has been a fantastic year for equity investors as Donald Trump pressured Federal Reserve to reduce interest rates and finalized the first leg of a trade deal with China.
Alnylam Pharmaceuticals, Inc. (ALNY): These Hedge Funds Cashed Out Too Early
At Insider Monkey, we pore over the filings of nearly 750 top investment firms every quarter, a process we have now completed for the latest reporting period.
Hedge Funds Have Never Been More Bullish On Alnylam Pharmaceuticals, Inc. (ALNY)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Here’s What Hedge Funds Think About Alnylam Pharmaceuticals, Inc. (ALNY)
Hedge fund managers like David Einhorn, Bill Ackman, or Carl Icahn became billionaires through reaping large profits for their investors, which is why piggybacking their stock...
Here is What Hedge Funds Think About Alnylam Pharmaceuticals, Inc. (ALNY)
"Market conditions are changing.
Hedge Funds Are Dumping Alnylam Pharmaceuticals, Inc. (ALNY)
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset...
Market Movers Today: Alnylam Pharmaceuticals, Inc. (ALNY), Snap Inc (SNAP), Sellas Life Sciences Group Inc (SLS), Intel Corporation (INTC), and More
What happened: Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), a precommercial pioneer of RNA-based therapies, continued a slide that began just ahead of the weekend.
32 Major Stories Summarizing What’s Happening in the World of Finance Today
"The S&P 500 and the Nasdaq Composite hit fresh intraday records on Monday as a jump in oil prices to a two-week high lifted Wall Street sentiment.
5 Stocks The Best Performing Hedge Funds Are Piling Into
At Insider Monkey, we track more than 700 of the best hedge funds in the world and have developed various market-beating strategies over the years using the wealth of data we ...
Is Alnylam Pharmaceuticals, Inc. (ALNY) A Good Stock To Buy Right Now?
The worries about the election and the ongoing uncertainty about the path of interest-rate increases have been keeping investors on the sidelines.
SYNNEX, Hibbett Sports, and Alnylam Among 5 Stocks With Notable Insider Trading
U.S indexes have opened lower this morning, as the trading week has kicked off with a plunge in global bonds courtesy of inflation fears.
Here’s What Happened With Alnylam Pharmaceuticals, Inc. (ALNY) and Tenax Therapeutics Inc (TENX)
A couple of companies have had a tough twenty-four hours in the biotech space.
Why Yum, Booz Allen Hamilton, Alnylam, and More Are in the Spotlight
Many traders are watching crude futures today to see if WTI can break out of the $50 per barrel mark.
Alnylam Pharmaceuticals, Inc. (ALNY): Eastern Capital Owns 3.8 Million Shares
Given the volatile nature of the markets, investors should pay attention to the latest moves made by elite hedge funds and other investors in their conviction picks, to get a ...
Hedge Funds Aren’t Crazy About Alnylam Pharmaceuticals, Inc. (ALNY) Anymore
Hedge funds and other investment firms that we track manage billions of dollars of their wealthy clients' money, and needless to say, they are painstakingly thorough when analyzing...
The Medicines Company (MDCO) and Alnylam Pharmaceuticals Inc. (ALNY)’s Positive Phase I Results Support Hedge Funds’ Confidence in These Companies
On August 30, The Medicines Company (NASDAQ:MDCO) and Alnylam Pharmaceuticals Inc.
Bridger Management’s Top Picks
Bridger Management, led by Roberto Mignone, has filed its 13F with the SEC for the current reporting period.
5 Mid-Cap Stocks That Insiders Love
Recent research conducted at InsiderMonkey has shown that stocks bought by insiders tend to outperform market indexes.
Three Stocks That Have Wittnessed Millionaire Insider Purchases Lately
Tracking insider purchases can provide an investor with great ideas, just like keeping an eye on hedge fund moves.
Biogen Idec Inc (BIIB), ISIS Pharmaceuticals, Inc. (ISIS), Alnylam Pharmaceuticals, Inc. (ALNY): A Ringing Endorsement of a Technology Years in the Making
For the latest deal, Biogen Idec Inc (NASDAQ:BIIB) is giving Isis $100 million up front, and ISIS Pharmaceuticals, Inc.
Universal Health Services, Inc. (UHS), Alnylam Pharmaceuticals, Inc. (ALNY), Alere Inc (ALR): Health Care Companies Built for Growth
The health care sector has been one of the best performing sectors of 2013.
Alnylam Pharmaceuticals, Inc. (ALNY) & Conferences, Synta Pharmaceuticals Corp. (SNTA)’s Investors, Inovio Pharmaceuticals Inc (INO)’s Vaccinations
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today announced that management will present a company overview at the Morgan Stanley Global Healthcare Conference...
Viropharma Inc (VPHM): Are Hedge Funds Right About This Stock?
If you were to ask many traders, hedge funds are seen as useless, old investment vehicles of an era lost to time.
Hedge Funds Are Selling Arena Pharmaceuticals, Inc. (ARNA)
Now, according to many market players, hedge funds are viewed as delayed, outdated financial tools of an era lost to time.
Alnylam Pharmaceuticals, Inc. (ALNY): Insiders Aren’t Crazy About It But Hedge Funds Love It
If you were to ask many market players, hedge funds are seen as useless, outdated financial tools of a period lost to current times.
Pfizer Inc. (PFE), Regeneron Pharmaceuticals Inc (REGN): Are These Drugs the Future of High-Cholesterol Treatment?
Once upon a time in a regulatory environment far, far away, there was a cholesterol-fighting drug named Lipitor from Pfizer Inc. (NYSE:PFE).
Arena Pharmaceuticals, Inc. (ARNA): What Do The Smartest Investors Think?
In the financial world, there are tons of indicators investors can use to watch their holdings. Some of the most under-the-radar are hedge fund and insider trading sentiment.
Alnylam Pharmaceuticals, Inc. (ALNY): Here’s What The Smart Money Thinks
Is Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) the right investment to pursue these days? Hedge funds are taking a bullish view.
Alexion Pharmaceuticals, Inc. (ALXN), Onyx Pharmaceuticals, Inc. (ONXX): Will This Orphan Drug Maker Find a New Home?
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), already quite expensive, spiked higher since takeover rumors surfaced in early July.
Inovio Pharmaceuticals Inc (INO), Alnylam Pharmaceuticals, Inc. (ALNY): This Company Is in a Perfect Position to Take-off
In 2013, a number of new drugs got approvals from the FDA. This provided a boost to the biotech industry as a whole.
Amgen, Inc. (AMGN)’s Acquisition Ambition Leads Biotechs’ Rise
Biotech's the biggest boom-or-bust business on the market, with regulatory approvals and clinical trial results routinely sending stocks hurtling up or down by significant amounts...
ACADIA Pharmaceuticals Inc. (ACAD), Alnylam Pharmaceuticals, Inc. (ALNY) & Celldex Therapeutics, Inc. (CLDX): Buy These Biotech Companies for Long-Term Growth
According to IBISWorld, revenue of global biotechnology companies will surge to $262 billion this year, up by 12.7%, year-over-year.
Prosensa Holding BV (RNA), WebMD Health Corp. (WBMD): Three Humongous Health-Care Stocks This Week
If you thought the fireworks ended after the Fourth of July celebrations last week, think again.
